Literature DB >> 15019086

Acute exposure to aroclor 1016 or 1260 differentially affects dopamine transporter and vesicular monoamine transporter 2 levels.

Jason R Richardson1, Gary W Miller.   

Abstract

Polychlorinated biphenyls (PCBs) have been shown to specifically target the dopaminergic nervous system, resulting in long-term reduction of striatal dopamine (DA) levels. However, the mechanism(s) by which PCBs exert this effect is not known. Here we report that decreased striatal dopamine levels are observed 1, 7, and 14 days after acute exposure to the common PCB mixtures Aroclor 1016 or 1260. Dopamine transporter (DAT) levels were decreased at all time points in Aroclor 1016 treated animals, and on Days 1 and 7 in Aroclor 1260 treated animals. Vesicular monoamine transporter 2 (VMAT2) levels were not affected by Aroclor 1016, but were significantly decreased 14 days after exposure to Aroclor 1260. Tyrosine hydroxylase expression, a marker of dopamine neuron integrity, was not significantly affected by PCB exposure at any time. These data suggest that PCB-induced reductions in striatal dopamine may be mediated by alterations in DAT and VMAT2 expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019086     DOI: 10.1016/j.toxlet.2003.12.006

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  34 in total

Review 1.  Industrial toxicants and Parkinson's disease.

Authors:  W Michael Caudle; Thomas S Guillot; Carlos R Lazo; Gary W Miller
Journal:  Neurotoxicology       Date:  2012-01-30       Impact factor: 4.294

2.  Perinatal heptachlor exposure increases expression of presynaptic dopaminergic markers in mouse striatum.

Authors:  W Michael Caudle; Jason R Richardson; Minzheng Wang; Gary W Miller
Journal:  Neurotoxicology       Date:  2005-08       Impact factor: 4.294

Review 3.  The vesicular monoamine transporter 2: an underexplored pharmacological target.

Authors:  Alison I Bernstein; Kristen A Stout; Gary W Miller
Journal:  Neurochem Int       Date:  2014-01-04       Impact factor: 3.921

4.  High regulatability favors genetic selection in SLC18A2, a vesicular monoamine transporter essential for life.

Authors:  Zhicheng Lin; Ying Zhao; Chee Yeun Chung; Yanhong Zhou; Nian Xiong; Charles E Glatt; Ole Isacson
Journal:  FASEB J       Date:  2010-02-24       Impact factor: 5.191

5.  Developmental exposure to polychlorinated biphenyls reduces amphetamine behavioral sensitization in Long-Evans rats.

Authors:  Emily Poon; Supida Monaikul; Paul J Kostyniak; Lai Har Chi; Susan L Schantz; Helen J K Sable
Journal:  Neurotoxicol Teratol       Date:  2013-04-23       Impact factor: 3.763

6.  Pyrethroid pesticide-induced alterations in dopamine transporter function.

Authors:  Mohamed A Elwan; Jason R Richardson; Thomas S Guillot; W Michael Caudle; Gary W Miller
Journal:  Toxicol Appl Pharmacol       Date:  2005-07-11       Impact factor: 4.219

7.  Impairment in the mesohippocampal dopamine circuit following exposure to the brominated flame retardant, HBCDD.

Authors:  Camille Pham-Lake; Elizabeth B Aronoff; Chad R Camp; Aimee Vester; Sam J Peters; W Michael Caudle
Journal:  Environ Toxicol Pharmacol       Date:  2017-02-04       Impact factor: 4.860

Review 8.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

9.  Association between polychlorinated biphenyls and Parkinson's disease neuropathology.

Authors:  Jaime M Hatcher-Martin; Marla Gearing; Kyle Steenland; Allan I Levey; Gary W Miller; Kurt D Pennell
Journal:  Neurotoxicology       Date:  2012-08-18       Impact factor: 4.294

10.  Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosis.

Authors:  Thomas S Guillot; Seneshaw A Asress; Jason R Richardson; Jonathan D Glass; Gary W Miller
Journal:  J Mot Behav       Date:  2008-11       Impact factor: 1.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.